Anything to Stay Alive: The Challenges of a Campaign for an Experimental Drug-Reference-Cited by-同舟云学术

Anything to Stay Alive: The Challenges of a Campaign for an Experimental Drug

Published:2015-05-15 Issue:1 Volume:16 Page:45-54
ISSN:1471-8731
Container-title:Developing World Bioethics
language:en
Short-container-title:Developing World Bioeth

Author:

Geffen Nathan

Funder

Centre for Social Science Research, University of Cape Town

Publisher

Wiley

Subject

Health Policy,Health(social science),Issues, ethics and legal aspects

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dewb.12084/fullpdf

Reference89 articles.

1. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013;Murray;Lancet,2014

2. Statistics South Africa Mortality and causes of death in South Africa, 2012: Findings from death notification 2014

3. Case study: South Africa;Weyer;Bull World Health Organ,2007

4. N. Massyn C. Day N. Peer A. Padarath P. Barron R. English District Health Barometer 2013/14 2014 http://www.hst.org.za/publications/district-health-barometer-201314

5. World Health Organization Guidelines for treatment of tuberculosis 2010 http://www.who.int/tb/publications/2010/9789241547833/en/

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cycles of antibiotic use and emergent antimicrobial resistance in the South African tuberculosis programme (1950-2021): A scoping review and critical reflections on stewardship;Global Public Health;2024-05-21

2. A failure in solidarity: Ethical challenges in the development and implementation of new tuberculosis technologies;Bioethics;2019-01-25

3. Has compassionate use ever sunk a drug?;The International Journal of Tuberculosis and Lung Disease;2018-02-01

4. Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline;Journal of Antimicrobial Chemotherapy;2016-10-20

5. An analysis of common ethical justifications for compassionate use programs for experimental drugs;BMC Medical Ethics;2016-10-18